Fuso Pharmaceutical Industries, Ltd. (4538) - Financials, balance sheet (annual)

2,095 JPY

0.77%

Last update Jul 11, 3:22 PM JST

Market closed

Day range

2,095

2,086

2,100

Previous close

2,079

Open

2,086

Access this stock data via API

Fuso Pharmaceutical Industries, Ltd.

2,095.00

0.77%

Financials

Balance sheet

Fiscal date	2025	2024	2023	2022
Total assets	81.7B	75.8B	72.5B	69.3B
Current assets	48.3B	44.9B	43.2B	39.8B
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	6.3B	5.1B	8.0B	7.3B
Other short term investments	—	—	—	—
Accounts receivable	26.5B	24.3B	21.7B	21.2B
Other receivables	—	—	—	—
Inventory	14.9B	14.2B	12.5B	10.5B
Prepaid assets	558M	460M	443M	221M
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	88M	837M	571M	557M
Non current assets	33.4B	30.9B	29.2B	29.5B
Properties	12M	15M	0	3M
Land and improvements	8.8B	8.8B	8.8B	8.8B
Machinery furniture equipment	34.5B	34.0B	33.0B	31.6B
Construction in progress	174M	246M	1.7B	1.1B
Leases	—	—	—	—
Accumulated depreciation	-57.4B	-55.4B	-54.2B	-52.3B
Goodwill	1.5B	600M	329M	453M
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	1.5B	600M	329M	453M
Investments and advances	—	—	—	—
Other non current assets	1.2B	1.2B	1.3B	1.3B
Total liabilities	48.7B	39.1B	36.8B	34.8B
Current liabilities	44.1B	29.7B	28.5B	26.4B
Accounts payable	4.0B	7.4B	6.0B	6.1B
Accrued expenses	—	—	—	—
Short term debt	18.8B	6.7B	6.9B	6.3B
Deferred revenue	—	—	—	—
Tax payable	949M	270M	426M	137M
Pensions	1.0B	942M	951M	933M
Other current liabilities	8.7B	12.9B	12.8B	11.3B
Non current liabilities	4.6B	9.5B	8.3B	8.4B
Long term provisions	108M	108M	108M	108M
Long term debt	2.5B	7.0B	5.7B	5.8B
Provision for risks and charges	—	—	—	—
Deferred liabilities	1.3B	1.3B	1.3B	1.3B
Derivative product liabilities	—	—	—	—
Other non current liabilities	164M	158M	126M	127M
Shareholders equity
Common stock	10.8B	10.8B	10.8B	10.8B
Retained earnings	7.3B	11.2B	10.5B	9.4B
Other shareholders equity	—	—	—	—
Total shareholders equity	33.0B	36.7B	35.6B	34.5B
Additional paid in capital	15.0B	15.0B	15.0B	15.0B
Treasury stock	2.6B	2.6B	2.2B	2.2B
Minority interest	—	—	—	—